36. Johns Hopkins Hospital, Arcara K, Tschudy M, Lee CKD. The Harriet Lane Handbook: A Manual for Pediatric House Officers, 19th ed. Elsevier, Philadelphia, PA; 2010.
37. Yoon EY, Clark SJ, Gorman R, Nelson S, O’Connor KG, Freed GL. Differences in pediatric drug information sources used by general versus subspecialist pediatricians. Clin Pediatr (Phila) 2010;49:743-9.
38. Barrett JS, Narayan M, Patel D, Zuppa AF, Adamson PC. Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance. BMC Pediatr 2011;11:25.
39. Zuppa AF, Adamson PC, Mondick JT, et al. Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children. J Clin Pharmacol 2005;45:1305-12.
40. Bradley JS, Nelson JC. Nelson’s Pocket Book of Pediatric Antimicrobial Therapy, 18th ed; 2010-2011 Edition. American Academy of Pediatrics, Elk Grove Village, IL; 2010.
41. Tarascon Pharmacopoeia. Jones and Bartlett Learning, Burlington, MA; 2011.
42. Williams J, Klinepeter K, Palmes G, Pulley A, Meschan Foy J. Behavioral health practices in the midst of black box warnings and mental health reform. Clin Pediatr (Phila) 2007;46:424-30.
43. Cheung A, Sacks D, Dewa CS, Pong J, Levitt A. Pediatric prescribing practices and the FDA black-box warning on antidepressants. J Dev Behav Pediatr 2008;29:213-5.
44. Heneghan A, Garner AS, Storfer-Isser A, Kortepeter K, Stein RE, McCue Horwitz S. Use of selective serotonin reuptake inhibitors by pediatricians: comparing attitudes of primary care pediatricians and child and adolescent psychiatrists. Clin Pediatr (Phila) 2008;47:148-54.
45. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006;117:1979-87.
46. Spurling GK, Mansfield PR, Montgomery BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med 2010;7:e1000352.
47. Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. The National Academies Press, Washington, DC; 2009. (Accessed March 14, 2012 at http://books.nap.edu/openbook.php?record_id=12598.)
48. WebMD. 2011. (Accessed at www.webmd.com.)
49. Lexi-Comp Online. 2011. (Accessed at www.lexi.com.)
50. Micromedex. 2011. (Accessed at www.micromedex.com.)
51. Physicians’ Desk Reference. 2011. (Accessed at www.pdr.net.)
52. Drug Facts and Comparisons. 2011. (Accessed at www.factsandcomparisons.com.)
53. Cheng CL, Yang YH, Lin SJ, Lin CH, Lin YJ. Compliance with dosing recommendations from common references in prescribing antibiotics for preterm neonates. Pharmacoepidemiol Drug Saf 2010;19:51-8.
54. Clauson KA, Marsh WA, Polen HH, Seamon MJ, Ortiz BI. Clinical decision support tools: analysis of online drug information databases. BMC Med Informatics Decision Making 2007;7:7.
55. Lyman JA, Conaway M, Lowenhar S. Formulary access using a PDA-based drug reference tool: does it affect prescribing behavior? AMIA Annual Symposium Proceedings. 2008;1034.